Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Jun 19, 2024 10:07am
62 Views
Post# 36095774

RE:Elmer Fudd, where is the LABS press release? You are

RE:Elmer Fudd, where is the LABS press release? You are piduks, there is no doubt Labs can do a much better job in the promo dept. as I was under the impression AVCN and LABS were working together on the SEDDS technology.

Has this relationship changed?

https://www.avicanna.com/avicanna-and-medipharm-labs-expand-strategic-manufacturing-agreement-for-avicannas-proprietary-sedds-technology-capsules-for-canadian-and-international-markets/

Albeit, this AVCN news is just a patent approval, and not a FDA approval, but still a big step forward and we should have heard something from Labs if they are a part of this success.. 


Reminds me of the 2019 trial conducted by Dr. Jasmin Hurd regarding CBD affectiveness for opioid addiction. Medipharm was supplying the CBD for this heavily hyped medical trial, but nothing appears to of materialized, and nothing was reported to shareholders by the corporation.

 https://money.cnn.com/news/newsfeeds/articles/globenewswire/7626626.htm

<< Previous
Bullboard Posts
Next >>